Cartesian Therapeutics, Inc. Variable Lease, Cost
Cartesian Therapeutics, Inc. (RNAC) reported Variable Lease, Cost of $419.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- Cartesian Therapeutics, Inc. variable lease, cost for the quarter ending 2026-06-30 was $419.00K, a 1.64% decline year-over-year.
- Cartesian Therapeutics, Inc. variable lease, cost for the quarter ending 2026-03-31 was $431.00K, a 6.16% increase year-over-year.
- Cartesian Therapeutics, Inc. variable lease, cost for the quarter ending 2025-12-31 was $454.00K, a 5.42% decline year-over-year.
- Cartesian Therapeutics, Inc. variable lease, cost for the quarter ending 2025-09-30 was $438.00K, a 15.26% increase year-over-year.
- Cartesian Therapeutics, Inc. variable lease, cost for fiscal 2025 was $1.72M, a 7.15% increase from fiscal 2024.
- Cartesian Therapeutics, Inc. variable lease, cost for fiscal 2024 was $1.61M, a 66.74% increase from fiscal 2023.
- Cartesian Therapeutics, Inc. variable lease, cost for fiscal 2023 was $965.00K, a 6.04% increase from fiscal 2022.
- Cartesian Therapeutics, Inc. variable lease, cost for fiscal 2022 was $910.00K, a 9.11% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $419.00K 10-Q · filed 2026-08-06 | $850.00K 10-Q · filed 2026-08-06 | $1.30M derived: sum of 3 quarters · filed 2026-08-06 | $1.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $431.00K 10-Q · filed 2026-04-30 | $885.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.32M derived: sum of 3 quarters · filed 2026-04-30 | $1.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $892.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.32M derived: sum of 3 quarters · filed 2026-08-06 | $1.72M 10-K · filed 2026-03-09 |
| 2025-09-30 | $438.00K 10-Q · filed 2025-11-06 | $864.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.27M 10-Q · filed 2025-11-06 | $1.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $426.00K 10-Q · filed 2026-08-06 | $832.00K 10-Q · filed 2026-08-06 | $1.31M derived: sum of 3 quarters · filed 2026-08-06 | $1.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $406.00K 10-Q · filed 2026-04-30 | $886.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.27M derived: sum of 3 quarters · filed 2026-04-30 | $1.62M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $860.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.21M derived: sum of 3 quarters · filed 2026-03-09 | $1.61M 10-K · filed 2026-03-09 |
| 2024-09-30 | $380.00K 10-Q · filed 2025-11-06 | $732.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.13M 10-Q · filed 2025-11-06 | $1.41M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $352.00K 10-Q · filed 2025-08-07 | $749.00K 10-Q · filed 2025-08-07 | $1.03M derived: sum of 3 quarters · filed 2025-08-07 | $1.30M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $397.00K 10-Q · filed 2025-05-08 | $679.00K derived: sum of 2 quarters · filed 2025-05-08 | $950.00K derived: sum of 3 quarters · filed 2025-05-08 | $1.22M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $553.00K derived: sum of 2 quarters · filed 2025-03-13 | $823.00K derived: sum of 3 quarters · filed 2025-03-13 | $965.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $271.00K 10-Q · filed 2024-11-07 | $541.00K derived: sum of 2 quarters · filed 2024-11-07 | $683.00K 10-Q · filed 2024-11-07 | $963.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $270.00K 10-Q · filed 2024-08-08 | $412.00K 10-Q · filed 2024-08-08 | $692.00K derived: sum of 3 quarters · filed 2024-08-08 | $897.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $142.00K 10-Q · filed 2024-05-08 | $422.00K derived: sum of 2 quarters · filed 2024-05-08 | $627.00K derived: sum of 3 quarters · filed 2024-05-08 | $832.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $485.00K derived: sum of 2 quarters · filed 2024-03-07 | $690.00K derived: sum of 3 quarters · filed 2024-03-07 | $910.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $205.00K 10-Q · filed 2023-11-13 | $410.00K derived: sum of 2 quarters · filed 2023-11-13 | $630.00K 10-Q · filed 2023-11-13 | $812.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $205.00K 10-Q · filed 2023-08-17 | $425.00K 10-Q · filed 2023-08-17 | $607.00K derived: sum of 3 quarters · filed 2024-03-07 | $789.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $220.00K 10-Q · filed 2023-05-04 | $402.00K derived: sum of 2 quarters · filed 2024-03-07 | $584.00K derived: sum of 3 quarters · filed 2024-03-07 | $766.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $364.00K derived: sum of 2 quarters · filed 2024-03-07 | $546.00K derived: sum of 3 quarters · filed 2024-03-07 | $834.00K 10-K · filed 2024-03-07 |
| 2021-09-30 | $182.00K 10-Q · filed 2022-11-03 | $364.00K derived: sum of 2 quarters · filed 2022-11-03 | $652.00K 10-Q · filed 2022-11-03 | $780.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $182.00K 10-Q · filed 2022-08-08 | $470.00K 10-Q · filed 2022-08-08 | $598.00K derived: sum of 3 quarters · filed 2023-03-02 | $721.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $288.00K 10-Q · filed 2022-05-05 | $416.00K derived: sum of 2 quarters · filed 2023-03-02 | $539.00K derived: sum of 3 quarters · filed 2023-03-02 | $713.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $251.00K derived: sum of 2 quarters · filed 2023-03-02 | $425.00K derived: sum of 3 quarters · filed 2023-03-02 | $624.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $123.00K 10-Q · filed 2021-11-09 | $297.00K derived: sum of 2 quarters · filed 2021-11-09 | $496.00K 10-Q · filed 2021-11-09 | $699.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $174.00K 10-Q · filed 2021-08-12 | $373.00K 10-Q · filed 2021-08-12 | $576.00K derived: sum of 3 quarters · filed 2022-03-10 | $787.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $199.00K 10-Q · filed 2021-05-13 | $402.00K derived: sum of 2 quarters · filed 2022-03-10 | $613.00K derived: sum of 3 quarters · filed 2022-03-10 | $824.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $414.00K derived: sum of 2 quarters · filed 2022-03-10 | $625.00K derived: sum of 3 quarters · filed 2022-03-10 | $828.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $211.00K 10-Q · filed 2020-11-05 | $422.00K derived: sum of 2 quarters · filed 2020-11-05 | $625.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $211.00K 10-Q · filed 2020-08-06 | $414.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $203.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |